Responsible for the financial statements of JTI top holding and 10 other JTI entities, including the entity issuing external bonds.Primary contact for the audit partner.Handling external reporting to various authorities and internal reporting to the management and for group purposes.Optimization of cash flows, including capital contributions, capital repayments, dividends, and internal and external loans.Coaching team members and acting as a technical point of contact.

Qmulus is a Dutch investment company that provides capital, entrepreneurial knowledge, and experience to successful and innovative SMEs in the Netherlands with high ambitions.- Responsible for all financial matters within the entire direct investment portfolio, maintaining close contact with the management of the entities and the Qmulus CFO and CEO.- Analyzed and monitored the performance of direct investments and advised the boards of the entities.- Monthly and ad-hoc reporting to shareholders and financial institutions.- Management of the audit and financial statement process.- Full-fledged discussion partner for the external accountant, outsourced financial administration, tax advisor, and other external (M&A) advisors.

- Responsible for the statutory (consolidated) financial statements of all Dutch BP entities (Dutch GAAP and IFRS) and other financial reporting, ensuring high quality and timely delivery; primary contact for the audit partner and senior manager.- Designed, implemented, and maintained a robust corporate governance structure and process, resulting in improved informed decision-making, increased efficiency, enhanced compliance with policies, laws, and regulations, and improved risk management.- Built and maintained a strong internal and external cross-border and functional network (Business / Finance / Treasury / Tax / Legal), resulting in time-saving and effective workflows, well-informed decision-making by key officials in a complex organization, and improved risk management.- Initiated and implemented various simplification and cost-saving projects, including an annual saving of over $500k by reducing the number of Dutch and Belgian entities, and developing a dividend policy and an online training for statutory directors with over 150 participants.- Enhanced personal performance and employee satisfaction by coaching colleagues and being a mentee of the CEO of BP Europe SE (Germany).

As a shareholder representative on behalf of BP supervised the strategy, results and outlook. In addition, I have been actively involved in various processes to improve corporate governance.

- Oversaw the strategy, results, and outlook of this joint venture on behalf of BP.- Actively involved in the management committee of Combined Refueling Services, one of the three companies responsible for refueling aircraft at Schiphol.

- Delivered consistent, high-quality, and timely financial performance reporting at both consolidated and business segment levels, providing key insights for the Board of Directors, the Supervisory Board, and shareholders.- Ensured timely delivery of high-quality annual reports and acted as the primary contact for the external auditor.- Provided significant support for post-acquisition activities.- Executed complex projects, including purchase price allocation valuation and preparation of the first integrated N.V. Nuon Energy annual report.- Member of the Vattenfall Group Management System Committee.

- Led efficient and well-planned M&A assignments for well-known PE firms and companies, resulting in a clear understanding of potential risks and opportunities and support to unlock value (including cash flow, working capital, and forecast analyses).- Coached team members to the next level.

• Performed high-quality financial audits on international and midsized companies in various sectors (Shell, Damen Shipyards, Volkers Wessels, Pfizer, SBM, IHC, Boskalis), within agreed deadlines and budget• Coached team members to the next level• Seconded to KPMG Singapore (2005-2006)• Core team member of the audit of the independent figures and other financial information as stated in the prospectus for the intended IPO of Organon Biosciences N.V. (USD 10 billion)• Lecturer internal courses